Onto Innovation
ONTO
$198.67
-10.57%
Onto Innovation Inc. designs, manufactures, and supports high-performance process control metrology, defect inspection, lithography, and data-analytics systems used by microelectronics manufacturers, operating within the semiconductor capital equipment industry and deriving the bulk of its revenue from customers in Taiwan and South Korea. The company occupies a specialized niche as a supplier of yield-critical inspection and metrology tools rather than a broad-line lithography or deposition vendor, giving it a distinct position tied to advanced packaging, specialty devices, and increasingly to AI-driven chip manufacturing complexity. The current investor narrative centers on Onto's leverage to AI accelerator production and advanced packaging demand, reinforced by a strategic partnership highlighted in recent coverage, alongside a striking fundamental inflection: Q2 2026 revenue grew 35.3% year-over-year to $343.1 million with gross margin expanding to 53.4%. That bullish narrative is now colliding with a sharp share-price drawdown of roughly 42% from the 52-week high, setting up a live debate over whether the pullback is a valuation reset in an otherwise intact growth story or an early signal of order softness in a notoriously cyclical equipment market.…
ONTO
Onto Innovation
$198.67
ONTO 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Onto Innovation's 12-month outlook, with a consensus price target around $383.33 and implied upside of +93.0% versus the current price.
Average Target
$383.33
0 analysts
Implied Upside
+93.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$330 - $450
Analyst target range
Coverage is robust with 12 analysts, and the consensus is emphatically bullish: the recommendation is strong_buy with a mean rating of 1.25, and the average target price of $387.50 implies roughly +75.6% upside from the current $220.70. That gap is extraordinary and reflects a sell-side community that has not marked targets down to the recent price action — the average target sits essentially at the 52-week high of $386.46, suggesting analysts view the drawdown as a dislocation rather than a fundamental deterioration. The consensus leans strongly bullish, with estimated average revenue of $3.25 billion and average EPS of $21.93 underpinning the targets.
The full target range spans $330.00 to $450.00, a spread of about 36% around the average that signals meaningful disagreement about the magnitude of the AI-driven opportunity. The high target of $450 assumes multiple expansion on top of accelerating growth and successful capture of advanced-packaging and AI chip inspection demand, while the low target of $330 still implies roughly +49.5% upside and prices in continued execution with some margin compression. Institutional ratings show a consistent pattern of reaffirmations rather than fresh upgrades — Morgan Stanley at Overweight (September 8), Needham, Evercore ISI, and Jefferies all reiterating Buy/Outperform on August 7, and Cantor and Oppenheimer maintaining Outperform in June — indicating stable conviction but also a lack of new catalysts driving estimate revisions. The wide target spread combined with the stock trading 43% below the average target is a high-conviction-versus-high-uncertainty setup: the sell side sees deep value, but the market's price action is voting otherwise, and the divergence itself is the key risk signal to monitor.
Bulls vs Bears: ONTO Investment Factors
The bull case rests on hard, current-quarter evidence: 35.3% revenue growth, gross margin at 53.4%, a debt-free balance sheet, and a sell-side consensus target 75.6% above the current price. The bear case rests on price action and valuation arithmetic: a 42.31% drawdown with accelerating negative momentum, 35x EV/EBITDA, and a forward EPS estimate that looks disconnected from the $1.22 quarterly run-rate. On balance the fundamental evidence is currently stronger than the technical evidence — the company is executing at a high level — but the market is voting otherwise, and in semi-cap the market is often early rather than wrong. The single most important tension is whether the Q2 2026 revenue and margin inflection is the start of a durable AI-driven order cycle or the peak of a shipment burst ahead of an order digestion period; that question, not the multiple, will determine the next 12 months.
Bullish
- Revenue accelerating at 35% YoY: Q2 2026 revenue of $343.1 million grew 35.3% year-over-year and 17.5% sequentially from $291.9 million, capping a four-quarter run of $218.2M → $266.9M → $291.9M → $343.1M. Sequential acceleration of this magnitude is rare in semi-cap and points to genuine AI/advanced-packaging demand rather than a one-off shipment.
- Gross margin expansion to 53.4%: Gross margin climbed from 46.4% in Q4 2025 to 50.1% in Q1 2026 to 53.4% in Q2 2026, while operating margin rose to 18.5% from 12.7% a year earlier. This mix-driven expansion means incremental revenue is dropping through at very high contribution margins.
- Fortress balance sheet, self-funding: Debt-to-equity is just 0.0083 and the current ratio is 5.79, with $1.25 billion of cash after a $1.47 billion debt repayment and $205.0 million of buybacks. TTM free cash flow of $252.5 million against $3.7 million of quarterly capex confirms a capital-light model with roughly 94% FCF conversion.
- Analyst targets imply 75.6% upside: Twelve analysts carry a strong_buy consensus (mean rating 1.25) with an average target of $387.50 versus the $220.70 price, and even the low target of $330.00 implies +49.5% upside. The average target sits essentially at the 52-week high of $386.46, showing the sell side views the drawdown as dislocation.
Bearish
- Falling knife: -42.3% max drawdown: The stock has fallen from a $386.46 high to $220.70, a 42.31% max drawdown, and sits at just 37.9% of its 52-week range. Down 9.42% in one month and 21.14% in three months with a -4.85% latest session on 1.24 million shares, there is no evidence of stabilization yet.
- Severe and widening relative weakness: Six-month relative strength is -31.58 versus SPY and three-month is -23.83, while the one-year figure remains +47.20. That divergence is the classic signature of a high-beta leader (beta 1.581) unwinding, with longer-term outperformance being rapidly consumed by a short-term trend reversal.
- Forward EPS estimate looks unrealistic: The consensus EPS of $21.93 implies earnings roughly tripling from a quarterly run-rate of $1.22, and the trailing PE of 59.67x versus forward PE of 18.87x is an unusually wide gap. If estimates are cut toward the actual run-rate, the 'cheap' forward multiple disappears instantly.
- EV/EBITDA of 35x leaves no room for error: At 35.01x EV/EBITDA and 9.80x EV/Sales, Onto trades at a meaningful premium to large-cap semi-cap peers in the high-teens to mid-20s on EBITDA. In a cyclical equipment market, that multiple demands continued execution and offers little cushion if orders soften.
ONTO Technical Analysis
Onto is in a violent intermediate downtrend within a still-positive longer-term uptrend, having fallen from a 52-week high of $386.46 to $220.70, which places the stock at just 37.9% of its 52-week range and only 85.5% above the $118.97 low. Despite this collapse, the 1-year change remains +62.73%, meaning the stock has surrendered a large majority of its trailing-year gains in a matter of months and now sits near the lower third of its annual range — a positioning that flags momentum breakdown rather than a clean value setup. The -42.31% max drawdown confirms this is a falling-knife pattern until proven otherwise, and the proximity to the 52-week low area raises the stakes for anyone attempting to catch the decline.
Short-term momentum is decisively negative and accelerating: the stock is down 9.42% over the past month and 21.14% over three months, with the most recent session alone shedding 4.85% on 1.24 million shares. The 6-month change of -24.10% versus a +7.48% gain in SPY produces a relative strength reading of -31.58 over six months and -23.83 over three months, showing severe and widening underperformance against the market. Critically, the 1-month relative strength of -10.64 diverges sharply from the +47.20 one-year relative strength, a classic signature of a high-beta leader unwinding — the longer-term outperformance is being rapidly consumed by a short-term trend reversal, and the absence of any stabilization in the latest prints argues against calling a bottom yet.
Key technical levels are unusually well defined: resistance sits at the $386.46 52-week high, with intermediate supply likely near the $300-$330 zone where the stock repeatedly failed in August and September, while support rests at the $118.97 52-week low, with the $220 handle now being tested after the October slide. A decisive break below $220 would open the door toward the $200 psychological level and potentially the low-$200s, whereas reclaiming $250-$260 would be the first evidence of a tradable base. With a beta of 1.581, Onto is roughly 58% more volatile than the market, meaning position sizing should be materially smaller than a market-beta equivalent and stop-loss discipline is essential given the stock's demonstrated capacity for 20%+ swings within weeks.
Beta
1.58
1.58x market volatility
Max Drawdown
-47.5%
Largest decline past year
52-Week Range
$119-$386
Price range past year
Annual Return
+58.3%
Cumulative gain past year
| Period | ONTO Return | S&P 500 |
|---|---|---|
| 1m | -30.0% | -1.2% |
| 3m | -27.1% | +3.4% |
| 6m | -35.5% | +7.0% |
| 1y | +58.3% | +14.4% |
| ytd | +19.8% | +12.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ONTO Fundamental Analysis
Revenue is inflecting sharply upward: Q2 2026 revenue of $343.1 million grew 35.3% year-over-year versus $253.6 million in Q2 2025, and rose 17.5% sequentially from Q1 2026's $291.9 million, which itself was up 9.5% from Q4 2025's $266.9 million. The multi-quarter trajectory — $218.2M (Q3 2025), $266.9M (Q4 2025), $291.9M (Q1 2026), $343.1M (Q2 2026) — shows accelerating sequential growth, and segment data confirms systems and software revenue of $294.0 million dominates the mix, supplemented by $28.7 million in parts and $20.4 million in service. This is a genuine growth acceleration story, and the recurring parts and service base provides a stabilizing annuity layer beneath the lumpier systems business.
Profitability has expanded materially: Q2 2026 net income reached $60.1 million (17.5% net margin) on gross margin of 53.4%, up from $33.9 million and a 48.2% gross margin in Q2 2025, while operating income of $63.6 million equates to an 18.5% operating margin versus 12.7% a year earlier. Gross margin has climbed steadily from 46.4% in Q4 2025 to 50.1% in Q1 2026 to 53.4% in Q2 2026, a clear expansion trend driven by richer systems mix and operating leverage on R&D of $38.9 million and SG&A of $57.4 million. The trailing figures in the key metrics (13.6% net margin, 49.7% gross margin, 13.2% operating margin) understate the current run-rate, which is an important distinction for anyone anchoring on stale TTM data.
The balance sheet is fortress-like: debt-to-equity is just 0.0083, the current ratio stands at 5.79, and cash reached $1.25 billion at the end of Q2 2026 after a $1.47 billion debt repayment and $205.0 million of buybacks, with free cash flow TTM of $252.5 million. Quarterly free cash flow of $57.9 million against $3.7 million of capex implies a capital-light model with roughly 94% FCF conversion of operating cash flow, and ROE of 6.5% and ROA of 4.8% are depressed by a large cash and investment pile rather than operating weakness. The company is fully self-funding, returns capital aggressively, and carries essentially no financial risk — the only caveat is that working capital absorbed $34.9 million in Q2 and inventory days remain elevated near 213, a watch item if demand cools.
Quarterly Revenue
$343129000.0B
2026-06
Revenue YoY Growth
+35.3%
YoY Comparison
Gross Margin
53.4%
Latest Quarter
Free Cash Flow
$252471000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ONTO Overvalued?
Because net income is positive ($60.1 million in Q2 2026), the PE ratio is the appropriate primary metric: the trailing PE of 59.67x against a forward PE of 18.87x implies the market expects earnings to roughly triple, a gap that is unusually wide and reflects both the depressed trailing base (TTM EPS of just $0.0168 per the key metrics, distorted by prior weak quarters) and an aggressive forward consensus. The forward multiple of 18.87x is not demanding in absolute terms for a semiconductor equipment grower, but the credibility of that number hinges entirely on the consensus EPS estimate of $21.93, which looks inconsistent with the current quarterly EPS run-rate of $1.22 and should be treated with caution.
On peer comparison, the stock trades at a PS ratio of 8.11x and EV/Sales of 9.80x against a gross margin of 49.7% and net margin of 13.6%, while EV/EBITDA of 35.01x and PCF of 24.82x sit at premium levels for the semiconductor equipment group; the PEG ratio of -1.86 is not meaningful given the earnings-base distortion. The premium is partially justified by 35% revenue growth and 53% gross margins, but the 35x EV/EBITDA multiple leaves little room for error in a cyclical industry, and the negative PEG signals that near-term earnings growth is not yet validating the multiple. Relative to a typical large-cap semi-cap peer trading in the high-teens to mid-20s on EV/EBITDA, Onto carries a meaningful premium that demands continued execution.
Historical context is revealing: the stock's own PE has ranged from roughly 12.6x (Q4 2022) to 197x (Q4 2025), with recent readings of 77.6x in Q2 2026 and 75.4x in Q1 2026, while PS has ranged from about 12.1x (Q2 2022) to 54.5x (Q2 2026). The current PS of 8.11x and PB of 3.88x are near the low end of the multi-year band, a stark contrast to the 54.5x PS reading in the historical table, suggesting the market has already de-rated the stock substantially — but the elevated trailing PE and EV/EBITDA of 35x show that on earnings-based measures it is not cheap, leaving the valuation dependent on the forward earnings inflection actually materializing.
PE
59.7x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 13x~78x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
35.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are modest but not zero. The balance sheet is essentially unlevered at 0.0083 debt-to-equity with a 5.79 current ratio and $1.25 billion of cash, so solvency risk is negligible; the real exposure is earnings volatility, since quarterly EPS has swung from $1.30 (Q1 2025) to $0.21 (Q4 2025) to $1.22 (Q2 2026) within six quarters. Working capital absorbed $34.9 million in Q2 and inventory days remain elevated near 213, meaning a demand pause would hit both revenue and cash conversion simultaneously. Revenue concentration is the structural vulnerability: the business is a single operating segment with $294.0 million of the $343.1 million coming from systems and software, and the customer base is concentrated in Taiwan and South Korea, so a single foundry capex cut would be felt immediately.
Market and competitive risks center on valuation compression. At 35.01x EV/EBITDA, 9.80x EV/Sales, and 24.82x price-to-cash-flow, Onto carries a premium to typical large-cap semi-cap peers in the high-teens to mid-20s on EBITDA, and with a beta of 1.581 it amplifies any sector rotation away from AI-linked equipment names. The stock has already de-rated sharply — PS of 8.11x versus a historical peak of 54.5x — which shows how fast multiple compression can occur in this name. Competitive risk is real but narrower than for broad-line vendors: Onto's niche is yield-critical inspection and metrology, where process control intensity rises with advanced packaging complexity, but it competes against much larger players with broader portfolios. Recent coverage (Zacks, October 2) frames Onto as an under-the-radar AI chip production play, which cuts both ways — it validates the growth narrative but also means the stock is sentiment-sensitive to any AI capex headline.
The worst-case scenario is a specific chain: AI accelerator orders get pulled forward into 2026, Q3/Q4 bookings decelerate, the $21.93 consensus EPS is cut toward the $4-$5 annualized run-rate implied by current quarterly earnings, and the forward multiple re-rates from 18.87x to a cyclical trough. In that path the stock breaks the $220 handle, tests the $200 psychological level, and gravitates toward the $118.97 52-week low — a loss of roughly 46% from the current $220.70. Even the analyst low target of $330.00 offers no downside protection because it sits 49.5% above the market price, meaning the sell side has not yet marked to the tape. A realistic adverse case is a retest of the $180-$200 zone (-9% to -18%), with a full cyclical unwind toward $119 representing the tail risk.